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Abstract
A rapid and sensitive H7 and N9 subtype-specific reverse
transcription loop-mediated isothermal amplification assay was
developed respectively for visual detection of human-infected
influenza A (H7N9) virus. The reaction was performed in one step
in a single tube at 63°C for 60 min with the addition of
hydroxynaphthol blue dye before amplification. The detection
limits of both subtype-specific assays were comparable to those of
validated H7 and N9 real-time PCR assays respectively and no
cross-detection was observed with influenza A pandemic H1N1,
H3N2, H5N1, H9N2 or influenza B virus. The assays were
evaluated further with H7N9 virus-infected clinical specimens.
Keywords: Colorimetric detection, hydroxynaphthol blue dye,
influenza A H7N9 virus, reverse transcription loop-mediated
isothermal amplification, subtype-specific
Original Submission: 16 April 2013; Accepted: 3 May 2013
Editor: D. Raoult
Article published online: 7 May 2013
Clin Microbiol Infect 2013; 19: E372–E375
10.1111/1469-0691.12263
Corresponding authors: X. J. Ma and Y. L. Shu, Key Laboratory for
Medical Virology, Ministry of Health, National Institute for Viral
Disease Control and Prevention, Chinese Centre for Disease Control
and Prevention, No.155, Changbai Road, Changping district, Beijing
102206, China
E-mails: maxj@ivdc.chinacdc.cn; yshu@cnic.org.cn
*The first three authors contributed equally to this study.
Influenza A viruses can infect humans, birds, mammals and
other animals and are classified into subtypes based on viral
surface proteins, haemagglutinin (HA) and neuraminidase
(NA). There are currently 16 known HA subtypes (H1–16)
and nine known NA subtypes (N1–9) with many possible
combinations between HA and NA [1]. The first outbreak of
human infection with a novel reassortant influenza A (H7N9)
virus of avian origin was reported by the Chinese National
Influenza Centre (CNIC) [2]. As of 13 April 2013, a total of 44
cases have been laboratory confirmed with influenza A
(H7N9) virus infection in China, including 11 deaths.
Although there is no evidence of ongoing human-to-human
transmission at this time, early detection with a rapid, cost-
effective and efficient assay is in great demand to control the
potential epidemic in China, which has large populations and
relatively insufficient and uneven health resources. Currently,
CNIC has developed and distributed domestically validated
H7- and N9-specific quantitative real-time RT-PCR (qRT-PCR)
diagnostic kits for the detection of influenza A (H7N9) virus.
However, this method might not be suitable in primary clinical
settings or for field use because of the instrumentation
required, complicated assay procedures and expensive
reagents.
Loop-mediated isothermal amplification (LAMP) is a nucleic
acid amplification method developed by Notomi et al. [3], and
has emerged as a powerful gene amplification tool because of
its simplicity, speed, specificity and cost-effectiveness. LAMP
with hydroxynaphthol blue (HNB) dye was used in our
laboratory and is being reported increasingly for visual
detection and typing of viruses [4–9].
Because influenza A virus subtypes H1N1, H3N2, H5N1,
H7N2, H9N2 and influenza B virus are known to cause
clinically significant influenza-related disease in humans, the
aim of the current study was to develop a subtype-specific
reverse transcription (RT-LAMP) assay that is able to
differentiate influenza A H7N9 virus from subtypes H1,
H3, H5, H9 and subtypes N1, N2 and influenza B [10–17].
In the present study, an H7 and N9 subtype-specific RT-
LAMP and visual detection assay is described, in which the
reaction is carried out in a single tube at 63°C for 60 min.
The results can be observed and determined by HNB
dye-mediated visualization using the naked eye and without
opening the tubes after amplification.
Field isolates of human-infected influenza A viruses including
pandemic H1N1, H3N2, H5N1, H9N2 and influenza B from
the CNIC were used as control viruses to evaluate the
specificity of the type-specific RT-LAMP assay. All isolates had
been verified previously by virus isolation and full genome
sequencing. An isolated A/Anhui/1/2013 (H7N9) virus (circu-
lating virus of this outbreak) with an HA titre of 1 : 1024 from
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TABLE 1. Subtype-specific RT-loop-mediated isothermal amplification primers designed for the detection of the haemagglutinin
(HA) and neuraminidase (NA) gene sequences of human-infected influenza A H7N9 virus
Gene Primer name Genome position Sequence (5′–3′)
HA (Accession number in GISAID: EPI439507) F3 288–305 TGAGAGGCGAGAAGGAAG
B3 465–483 GAGCCATTTCATTTCTGCA
FIP (349–372)–(306–325) GCCTGATTCTCTGAGAATTTGCCTTGATGTCTGTTATCCTGGGA
BIP (378–399)–(435–453) TGACAAGGAAGCAATGGGATTCTCCTGATCTCCTACATGCA
LF 327–348 CAGAGCTTCTTCATTCACGAAT
LB 404–428 ACAGTGGAATAAGAACTAATGGAGC
NA (Accession number in GISAID: EPI439509) F3 151–168 ACCAACACAAGCCAAACA
B3 333–352 CATAGGGTTCTCTTGTGACT
FIP (224–248)–(184–206) AAGTTATTGAAATTCCTGCTTGTTCTATAATGAAACAAACATCACCAA
BIP (254–278)–(313–330) AAGGGCTCTGTACTATAAATTCATGAACATCCGAGCTCTCTCC
LF 207–223 TCTCTTCCATTTGGATG
LB 279–300 GCACATATATGGGAAAGACAAT
(a) (b)
(c) (d)
FIG. 1. Specificity and sensitivity analyses of subtype-specific reverse transcription loop-mediated isothermal amplification (RT-LAMP) assays for
the detection of human-infected influenza A H7N9 virus. (a,b) Colorimetric and turbidity analyses of the specificities of H7 (a) and N9 (b) subtype-
specific RT-LAMP assays for the detection of influenza A H7N9 virus. RT-LAMP reaction mixture contained 1 lL Bst 2.0 DNA polymerase (8 U/lL,
New England Biolabs, Ipswitch, MA, USA), 1 lL avian myeloblastosis virus reverse transcriptase (10 U/lL; Promega, Madison, WI, USA), 10 lL
reaction mix (Deaou Biotechnology Co., Ltd., Guang Zhou, China), 1 lL hydroxynaphthol blue (3 mM, Lemongreen, Shanghai, China) and 0.8 lL of
each primer (F3 and B3: 5 pmol/lL; BIP and FIP: 40 pmol/lL; Loop-F and Loop-B: 20 pmol/lL). The RT-LAMP reaction was incubated in a
conventional water bath at 63°C for 60 min. Tube 1: No template control (NTC); 2: human pandemic influenza A H1N1 virus (H1N1); 3: human
seasonal influenza A H3N2 virus; 4: human influenza A H5N1 virus; 5: human influenza H9N2 (G1) virus; 6: human influenza H9N2 (G9) virus; 7:
human influenza B virus (HB); 8: human influenza A H7N9 virus. (c,d) Colorimetric and turbidity analyses of the sensitivities of H7 (c) and N9 (d)
subtype-specific RT-LAMP assays for the detection of influenza A H7N9 virus and the comparison with qRT-PCR. Tubes 1–8: a serial ten-fold dilution
(101–108) of extracted reference virus. The qRT-PCR results were defined as positive for Ct not higher than 38 for both haemagglutinin and
neuraminidase genes and the corresponding Ct values are shown in parentheses.
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the CNIC was used as the reference virus. Five clinical throat
swab specimens (four from Jiangsu province and one from
Zhejiang province, China) with CNIC-confirmed H7N9 virus
infection using qPCR and virus isolation were also included in
this study.
The primers were designed based on sequence information
obtained from the Influenza Sequence Database (http://www.
gisaid.org/). All available sequences of human H1, H3, H5, H7
and H9 influenza virus, N1, N2 influenza virus and influenza B
virus from the database and A/Anhui/1/2013 (H7N9) virus
were compared. The most conserved segments within the HA
and NA genes of A/Anhui/1/2013 (H7N9) were selected as the
target. All primers were designed using a software program for
LAMP primer design (Eiken Chemical Co. Ltd., Tokyo, Japan)
and HPLC purified as shown in Table 1.
To test the specificity of the subtype-specific RT-LAMP
assay, total RNA was extracted from 140 lL of various
control viruses and the reference virus (HA titres: 1 : 32 to
1 : 1024) with the commercial QIAamp Viral RNA Mini Kit
(Qiagen, Hilden, Germany). The extracts were suspended in
60 lL distilled water. One microlitre of the extracts was
brought up to a total volume of 20 lL and the RT-LAMP was
performed as described in Fig. 1(a,b). A positive amplification
was indicated by a colour change from violet to sky blue and
verified by a turbidity value >0.2 using a real-time turbidimeter
LA320 (Eiken Chemical Co., Ltd., Tokyo, Japan). As shown in
Fig. 1(a,b) a positive colour (sky blue) was only observed in the
preparation of the reference virus, whereas none of the
control viruses showed a colour change in both subtype-
specific RT-LAMP assays.
To determine the detection limit of the subtype-specific RT-
LAMP assay, a serial ten-fold dilution of extracted reference
virus RNA was prepared. The RT-LAMP assay was performed
as described in Fig. 1(a,b) in parallel with the qRT-PCR assay
using the same RNA templates. The qRT-PCR results were
defined as the positive for Ct not higher than 38 for both HA
and NA genes. As shown in Fig. 1(c,d) the detection limits of
both subtype-specific RT-LAMP assays were comparable to
those of qRT-PCR assays (corresponding Ct values were 38.60
for HA and 35.56 for NA). The reaction at each template
concentration was repeated three times and similar results
were obtained. A ‘No template control’ was included in each
run.
The assay was further evaluated with extracted RNAs from
five clinical throat swab specimens from patients with influenza
A H7N9 infection and from eight patients with pandemic
H1N1, ten patients with influenza A H3N2 and two patients
with influenza B virus infection previously determined by
CNIC. Clear positive amplifications were detected from all of
five clinical samples within 30 min, but not from any of the 20
samples of pandemic H1N1, H3N2 or influenza B (data not
shown).
In addition, the sensitivity of the HNB dye-based assay is the
same as the turbidity assay and comparable to qRT-PCR (1 lL
RNA template used in RT-LAMP versus 5 lL used in qRT-
PCR).The cost of each type-specific RT-LAMP is less than $4
per test, compared with $8 per test using the qRT-PCR.
Though the validation was performed with a limited number of
clinical samples at present, the proposed RT-LAMP assays with
HNB dye are demonstrated to be rapid, sensitive, easy and
cost-effective and have potential usefulness for the screening
of human infection with influenza A (H7N9) virus in resource-
limited hospitals or rural clinics of provincial and municipal
regions in China.
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